nodes	percent_of_prediction	percent_of_DWPC	metapath
Bendroflumethiazide—TPMT—Methylation Pathways—COMT—attention deficit hyperactivity disorder	0.0567	0.191	CbGpPWpGaD
Bendroflumethiazide—TPMT—Methylation—COMT—attention deficit hyperactivity disorder	0.0521	0.175	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—forebrain—attention deficit hyperactivity disorder	0.0476	0.0678	CbGeAlD
Bendroflumethiazide—KCNMA1—cardiovascular system—attention deficit hyperactivity disorder	0.0403	0.0573	CbGeAlD
Bendroflumethiazide—CA1—forebrain—attention deficit hyperactivity disorder	0.0362	0.0515	CbGeAlD
Bendroflumethiazide—TPMT—midbrain—attention deficit hyperactivity disorder	0.0338	0.0481	CbGeAlD
Bendroflumethiazide—KCNMA1—midbrain—attention deficit hyperactivity disorder	0.0314	0.0447	CbGeAlD
Bendroflumethiazide—CA1—cardiovascular system—attention deficit hyperactivity disorder	0.0306	0.0435	CbGeAlD
Bendroflumethiazide—CA4—forebrain—attention deficit hyperactivity disorder	0.0283	0.0402	CbGeAlD
Bendroflumethiazide—TPMT—nervous system—attention deficit hyperactivity disorder	0.0278	0.0395	CbGeAlD
Bendroflumethiazide—TPMT—central nervous system—attention deficit hyperactivity disorder	0.0267	0.0381	CbGeAlD
Bendroflumethiazide—TPMT—cerebellum—attention deficit hyperactivity disorder	0.0261	0.0372	CbGeAlD
Bendroflumethiazide—KCNMA1—nervous system—attention deficit hyperactivity disorder	0.0258	0.0368	CbGeAlD
Bendroflumethiazide—KCNMA1—central nervous system—attention deficit hyperactivity disorder	0.0249	0.0354	CbGeAlD
Bendroflumethiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A9—attention deficit hyperactivity disorder	0.0244	0.082	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—cerebellum—attention deficit hyperactivity disorder	0.0243	0.0346	CbGeAlD
Bendroflumethiazide—CA4—cardiovascular system—attention deficit hyperactivity disorder	0.0239	0.034	CbGeAlD
Bendroflumethiazide—CA2—forebrain—attention deficit hyperactivity disorder	0.0234	0.0334	CbGeAlD
Bendroflumethiazide—TPMT—brain—attention deficit hyperactivity disorder	0.0212	0.0302	CbGeAlD
Bendroflumethiazide—CA2—cardiovascular system—attention deficit hyperactivity disorder	0.0198	0.0282	CbGeAlD
Bendroflumethiazide—KCNMA1—brain—attention deficit hyperactivity disorder	0.0198	0.0281	CbGeAlD
Bendroflumethiazide—CA1—nervous system—attention deficit hyperactivity disorder	0.0196	0.0279	CbGeAlD
Bendroflumethiazide—CA1—central nervous system—attention deficit hyperactivity disorder	0.0189	0.0269	CbGeAlD
Bendroflumethiazide—CA4—midbrain—attention deficit hyperactivity disorder	0.0187	0.0266	CbGeAlD
Bendroflumethiazide—CA2—midbrain—attention deficit hyperactivity disorder	0.0155	0.022	CbGeAlD
Bendroflumethiazide—CA4—nervous system—attention deficit hyperactivity disorder	0.0153	0.0218	CbGeAlD
Bendroflumethiazide—CA1—brain—attention deficit hyperactivity disorder	0.015	0.0214	CbGeAlD
Bendroflumethiazide—CA4—central nervous system—attention deficit hyperactivity disorder	0.0148	0.021	CbGeAlD
Bendroflumethiazide—CA4—cerebellum—attention deficit hyperactivity disorder	0.0144	0.0206	CbGeAlD
Bendroflumethiazide—CA2—nervous system—attention deficit hyperactivity disorder	0.0127	0.0181	CbGeAlD
Bendroflumethiazide—CA2—central nervous system—attention deficit hyperactivity disorder	0.0123	0.0174	CbGeAlD
Bendroflumethiazide—CA2—cerebellum—attention deficit hyperactivity disorder	0.012	0.017	CbGeAlD
Bendroflumethiazide—CA4—brain—attention deficit hyperactivity disorder	0.0117	0.0167	CbGeAlD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0109	0.0366	CbGpPWpGaD
Bendroflumethiazide—CA2—brain—attention deficit hyperactivity disorder	0.00973	0.0138	CbGeAlD
Bendroflumethiazide—KCNMA1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00931	0.0313	CbGpPWpGaD
Bendroflumethiazide—TPMT—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00915	0.0308	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.0062	0.0208	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00554	0.0186	CbGpPWpGaD
Bendroflumethiazide—TPMT—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00535	0.018	CbGpPWpGaD
Bendroflumethiazide—TPMT—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00531	0.0179	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00528	0.0178	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00528	0.0178	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00495	0.0167	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00495	0.0167	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.0048	0.0161	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00477	0.016	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00466	0.0157	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00434	0.0146	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00429	0.0144	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.0041	0.0138	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00381	0.0128	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00379	0.0127	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.0034	0.0114	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00289	0.00971	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00287	0.00964	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—EP300—attention deficit hyperactivity disorder	0.00271	0.0091	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00225	0.00758	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00219	0.00736	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00193	0.00648	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00161	0.00541	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00158	0.00532	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00152	0.0051	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00151	0.00508	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00151	0.00508	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00149	0.005	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00145	0.00489	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00138	0.00465	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00121	0.00406	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00115	0.00387	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00109	0.00367	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00109	0.00367	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00107	0.00361	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00105	0.00352	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00105	0.00352	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00103	0.00346	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.001	0.00338	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.001	0.00338	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000999	0.00336	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000988	0.00332	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000958	0.00322	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000918	0.00309	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—COMT—attention deficit hyperactivity disorder	0.000915	0.00308	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000909	0.00306	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000873	0.00294	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000837	0.00282	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000831	0.0028	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000803	0.0027	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000797	0.00268	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000769	0.00259	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000764	0.00257	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000662	0.00223	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000657	0.00221	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000634	0.00213	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00063	0.00212	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000608	0.00205	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000604	0.00203	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—EP300—attention deficit hyperactivity disorder	0.000393	0.00132	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—EP300—attention deficit hyperactivity disorder	0.000284	0.000954	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000272	0.000915	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000261	0.000877	CbGpPWpGaD
